TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -2 | 2 | -7 | -0 | 0 | -2 | -2 |
| S | %wins | 75 | 25 | 75 | 75 | 25 | 50 | 54 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/10 16:36 | 1/7/10 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Linda S | UT | D | S.d | -821 | 26.90 | 23 | -31 | -92 | 3 | D | 29 | -14 | 7 | -1 | 12 | 8 | -1 | -1 | -2 | -6 | -17 | -11 | -42 | -18 | |
12/10/08 13:21 | 12/9/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Linda S | UT | D | S.d | -1,023 | 63.91 | 33 | -16 | -86 | 3 | D | 102 | 25 | 37 | -4 | 11 | -6 | 5 | 3 | -4 | 3 | 6 | 32 | 21 | -14 | |
9/19/08 16:50 | 9/19/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Linda S | UT | D | S.d | -823 | 65.81 | 33 | -13 | -83 | 3 | D | 157 | 34 | 72 | 25 | -3 | -7 | -1 | -2 | -3 | 5 | -12 | 0 | 21 | 1 | |
12/4/07 17:29 | 11/30/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Linda S | UT | D | S.d | -1,204 | 48.17 | 33 | -25 | -91 | 3 | D | 150 | 58 | 30 | 8 | -7 | -1 | 4 | -2 | 2 | 4 | -5 | -22 | 1 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |